Article ; Online: Developing evolution-resistant drugs for COVID-19.
2022 Volume 11
Abstract: Analyzing how mutations affect the main protease of SARS-CoV-2 may help researchers develop drugs that are effective against current and future variants of the virus. ...
Abstract | Analyzing how mutations affect the main protease of SARS-CoV-2 may help researchers develop drugs that are effective against current and future variants of the virus. |
---|---|
MeSH term(s) | Antiviral Agents/pharmacology ; Antiviral Agents/therapeutic use ; COVID-19/drug therapy ; Coronavirus 3C Proteases ; Cysteine Endopeptidases ; Humans ; Molecular Docking Simulation ; Protease Inhibitors ; SARS-CoV-2 ; Viral Nonstructural Proteins |
Chemical Substances | Antiviral Agents ; Protease Inhibitors ; Viral Nonstructural Proteins ; Cysteine Endopeptidases (EC 3.4.22.-) ; Coronavirus 3C Proteases (EC 3.4.22.28) |
Language | English |
Publishing date | 2022-07-26 |
Publishing country | England |
Document type | Editorial ; Research Support, Non-U.S. Gov't |
ZDB-ID | 2687154-3 |
ISSN | 2050-084X ; 2050-084X |
ISSN (online) | 2050-084X |
ISSN | 2050-084X |
DOI | 10.7554/eLife.81334 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.